Literature DB >> 2604727

The specificity of bovine spleen cathepsin S. A comparison with rat liver cathepsins L and B.

D Brömme1, A Steinert, S Friebe, S Fittkau, B Wiederanders, H Kirschke.   

Abstract

The peptide-bond-specificity of bovine spleen cathepsin S in the cleavage of the oxidized insulin B-chain and peptide methylcoumarylamide substrates was investigated and the results are compared with those obtained with rat liver cathepsins L and B. Major cleavage sites in the oxidized insulin B-chain generated by cathepsin S are the bonds Glu13-Ala14, Leu17-Val18 and Phe23-Tyr26; minor cleavage sites are the bonds Asn3-Gln4, Ser9-His10 and Leu15-Tyr16. The bond-specificity of this proteinase is in part similar to the specificities of cathepsin L and cathepsin N. Larger differences are discernible in the reaction with synthetic peptide substrates. Cathepsin S prefers smaller neutral amino acid residues in the subsites S2 and S3, whereas cathepsin L efficiently hydrolyses substrates with bulky hydrophobic residues in the P2 and P3 positions. The results obtained from inhibitor studies differ somewhat from those based on substrates. Z-Phe-Ala-CH2F (where Z- represents benzyloxycarbonyl-) is a very potent time-dependent inhibitor for cathepsin S, and inhibits this proteinase 30 times more efficiently than it does cathepsin L and about 300 times better than it does cathepsin B. By contrast, the peptidylmethanes Z-Val-Phe-CH3 and Z-Phe-Lys(Z)-CH3 inhibit competitively both cathepsin S and cathepsin L in the micromolar range.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2604727      PMCID: PMC1133604          DOI: 10.1042/bj2640475

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  Acid sulphydryl protease from calf lymph nodes.

Authors:  T Turnsek; I Kregar; D Lebez
Journal:  Biochim Biophys Acta       Date:  1975-10-22

2.  [The primary structure of a human immunoglobin L-chain of kappa-type (Bence-Jones protein Scw) I: The tryptic peptides (author's transl)].

Authors:  M Eulitz; D Götze; N Hilschmann
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1974-07

3.  Action of cathepsin N on the oxidized B-chain of bovine insulin.

Authors:  P Evans; D J Etherington
Journal:  FEBS Lett       Date:  1979-03-01       Impact factor: 4.124

4.  Restrictions on the binding of proline-containing peptides to elastase.

Authors:  R C Thompson; E R Blout
Journal:  Biochemistry       Date:  1973-01-02       Impact factor: 3.162

5.  Comparison of ninhydrin, fluorescamine, and o-phthaldialdehyde for the detection of amino acids and peptides and their effects on the recovery and composition of peptides from thin-layer fingerprints.

Authors:  E Schiltz; K D Schnackerz; R W Gracy
Journal:  Anal Biochem       Date:  1977-05-01       Impact factor: 3.365

6.  Action of cathepsin L on the oxidized B-chain of bovine insulin.

Authors:  H J Kärgel; R Dettmer; G Etzold; H Kirschke; P Bohley; J Langner
Journal:  FEBS Lett       Date:  1980-06-02       Impact factor: 4.124

7.  Cathepsin L. A new proteinase from rat-liver lysosomes.

Authors:  H Kirschke; J Langner; B Wiederanders; S Ansorge; P Bohley
Journal:  Eur J Biochem       Date:  1977-04-01

8.  The active centers of Streptomyces griseus protease 3 and alpha-chymotrypsin. Enzyme-substrate interactions beyond subsite S'1.

Authors:  C A Bauer
Journal:  Biochim Biophys Acta       Date:  1976-07-08

9.  Cathepsin S from bovine spleen. Purification, distribution, intracellular localization and action on proteins.

Authors:  H Kirschke; B Wiederanders; D Brömme; A Rinne
Journal:  Biochem J       Date:  1989-12-01       Impact factor: 3.857

10.  Peptide methyl ketones as reversible inhibitors of cysteine proteinases.

Authors:  D Brömme; B Bartels; H Kirschke; S Fittkau
Journal:  J Enzyme Inhib       Date:  1989
View more
  20 in total

1.  Proteolytic mechanisms of cartilage breakdown: a target for arthritis therapy?

Authors:  D J Buttle; H Bramwell; A P Hollander
Journal:  Clin Mol Pathol       Date:  1995-08

Review 2.  Proteases and proteolysis in the lysosome.

Authors:  P Bohley; P O Seglen
Journal:  Experientia       Date:  1992-02-15

3.  High level expression and crystallization of recombinant human cathepsin S.

Authors:  D Brömme; M E McGrath
Journal:  Protein Sci       Date:  1996-04       Impact factor: 6.725

4.  Quantification of cathepsins B and L in cells.

Authors:  R Xing; A K Addington; R W Mason
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

5.  Amino acid substitutions in the N-terminal segment of cystatin C create selective protein inhibitors of lysosomal cysteine proteinases.

Authors:  R W Mason; K Sol-Church; M Abrahamson
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

6.  Inflammatory mediators regulate cathepsin S in macrophages and microglia: A role in attenuating heparan sulfate interactions.

Authors:  J P Liuzzo; S S Petanceska; D Moscatelli; L A Devi
Journal:  Mol Med       Date:  1999-05       Impact factor: 6.354

7.  Voltage-gated Sodium Channel Activity Promotes Cysteine Cathepsin-dependent Invasiveness and Colony Growth of Human Cancer Cells.

Authors:  Ludovic Gillet; Sébastien Roger; Pierre Besson; Fabien Lecaille; Jacques Gore; Philippe Bougnoux; Gilles Lalmanach; Jean-Yves Le Guennec
Journal:  J Biol Chem       Date:  2009-01-28       Impact factor: 5.157

8.  Quantifying cathepsin S activity in antigen presenting cells using a novel specific substrate.

Authors:  Nicolas Lützner; Hubert Kalbacher
Journal:  J Biol Chem       Date:  2008-10-28       Impact factor: 5.157

9.  Collagenolytic cysteine proteinases of bone tissue. Cathepsin B, (pro)cathepsin L and a cathepsin L-like 70 kDa proteinase.

Authors:  J M Delaissé; P Ledent; G Vaes
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

10.  Monitoring compartment-specific substrate cleavage by cathepsins B, K, L, and S at physiological pH and redox conditions.

Authors:  Silvia Jordans; Sasa Jenko-Kokalj; Nicole M Kühl; Sofia Tedelind; Wolfgang Sendt; Dieter Brömme; Dusan Turk; Klaudia Brix
Journal:  BMC Biochem       Date:  2009-09-22       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.